Expanding the Clinical Spectrum of Tacrolimus Optic Neuropathy

Affiliations

¹ Faculty of Medicine (IMH), University of Toronto, Toronto, Canada; Institute of Health Policy, Management, and Evaluation (IMH), University of Toronto, Toronto, Canada; Department of Ophthalmology and Vision Sciences (JAM), University of Toronto, Toronto, Canada; Division of Neurology, Department of Medicine (JAM), University of Toronto, Toronto, Canada; and Kensington Vision and Research Centre (JAM), Toronto, Canada.

Isra M Hussein et al. J Neuroophthalmol. 2023.

. 2023 Dec 1;43(4):e230-e232.

doi: 10.1097/WNO.0000000000001553. Epub 2022 Jun 14.

¹ Faculty of Medicine (IMH), University of Toronto, Toronto, Canada; Institute of Health Policy, Management, and Evaluation (IMH), University of Toronto, Toronto, Canada; Department of Ophthalmology and Vision Sciences (JAM), University of Toronto, Toronto, Canada; Division of Neurology, Department of Medicine (JAM), University of Toronto, Toronto, Canada; and Kensington Vision and Research Centre (JAM), Toronto, Canada.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

1. Rasool N, Boudreault K, Lessell S, Prasad S, Cestari DM. Tacrolimus optic neuropathy. J Neuroophthalmol. 2018;38:160–166.
1. Venneti S, Moss HE, Levin MH, Vagefi MR, Brozena SC, Pruitt AA, Mourelatos Z, Trojanowski JQ, Galetta SL, Balcer LJAsymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity. J Neurol Sci. 2011;301:112–115.
1. Ascaso FJ, Mateo J, Huerva V, Cristóbal JA. Unilateral tacrolimus-associated optic neuropathy after liver transplantation. Cutan Ocul Toxicol. 2012;31:167–170.
1. Demontes M, Thia-Soui-Tchong K, Ronsin S, Desestret V, Vighetto A, Tilikete C. Visual outcome improvement in tacrolimus-related bilateral optic neuropathy. J Neuroophthalmol. 2019;41:e22–e24.